Powders hold the largest share of the satiety supplements market at 34.3% in 2026, followed by glucomannan with a 32.0% share by ingredient and appetite suppression at 30.5% by function. Market adoption is driven by demand for effective weight-management solutions, clinically supported ingredients, and consistent product performance.